Experience with a subcutaneous implantable bone conduction hearing aid (Xomed Audiant) in a district general hospital.
Patients with a conductive hearing loss may find conventional hearing aids unsatisfactory for a variety of reasons. Efforts to overcome some of these difficulties have led to the development of the osteointegrated hearing aid. Implantable bone conduction hearing aids are an important advance in the treatment of well selected patients. Only 18 patients, who have been implanted with the Xomed Audiant bone conduction hearing aid, have so far been reported on in the UK. This report concerns a further six patients who have been implanted in one centre. Five of these patients continue to use their Audiant hearing aid 14 to 24 months after being fitted. They regard it to have significant advantages over their previous hearing aids. Four of the five patients use an ear level processor. Two of the patients who had previously used conventional bone conduction hearing aids now use the ear level processor.
Whitehead
E
E
Department of Otolaryngology and Head and Neck Surgery, Hull Royal Infirmary.
D000293:Adolescent; D001299:Audiometry; D003054:Cochlear Implants; D005260:Female; D005500:Follow-Up Studies; D006309:Hearing / Q000502:physiology; D006314:Hearing Loss, Conductive / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008297:Male